# Protagenic Therapeutics, Inc.\\new: Form 8-K, filed May 19, 2025

- Company: [Protagenic Therapeutics, Inc.\\new](/companies/ptix.md) (CIK 1022899)
- Form: 8-K
- Filed: 2025-05-19
- Accepted by EDGAR: May 19, 2025, 08:19 ET
- Period: 2025-05-15
- Accession: 0001641172-25-011387
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1022899/000164117225011387/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1022899/000164117225011387/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.01: Completion of an acquisition or disposition
- Item 3.02: Unregistered sale of equity
- Item 3.03: Change to security holders’ rights
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1022899/000164117225011387/form8-k.htm

Filed May 19, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-011387. Last ingested by Listed: Nov 6, 2026, 14:34 ET. No prices; not investment advice.